Q32 Bio Stock Odds of Future Stock Price Finishing Under 50.59
| QTTB Stock | 24.55 2.49 9.21% |
Q32 |
Q32 Bio Target Price Odds to finish below 50.59
The tendency of Q32 Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under 50.59 after 90 days |
| 24.55 | 90 days | 50.59 | about 88.28 |
Based on a normal probability distribution, the odds of Q32 Bio to stay under 50.59 after 90 days from now is about 88.28 (This Q32 Bio probability density function shows the probability of Q32 Stock to fall within a particular range of prices over 90 days) . Probability of Q32 Bio price to stay between its current price of 24.55 and 50.59 at the end of the 90-day period is about 88.28 .
Given the investment horizon of 90 days Q32 Bio has a beta of 1.0 indicating Q32 Bio market returns are sensitive to returns on the market. As the market goes up or down, Q32 Bio is expected to follow. Additionally Q32 Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Q32 Bio Price Density |
| Price |
Predictive Modules for Q32 Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Q32 Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Q32 Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Q32 Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Q32 Bio is not an exception. The market had few large corrections towards the Q32 Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Q32 Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Q32 Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.7 | |
β | Beta against Dow Jones | 1.00 | |
σ | Overall volatility | 5.83 | |
Ir | Information ratio | -0.14 |
Q32 Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Q32 Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Q32 Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Q32 Bio generated a negative expected return over the last 90 days | |
| Q32 Bio has high historical volatility and very poor performance | |
| Q32 Bio has high likelihood to experience some financial distress in the next 2 years | |
| Q32 Bio was previously known as Homology Medicines and was traded on NASDAQ Exchange under the symbol FIXX. | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Q32 Bio generates negative cash flow from operations | |
| About 74.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Q32 Bio Trading Down 0.9 percent - Heres Why - MarketBeat |
Q32 Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Q32 Stock often depends not only on the future outlook of the current and potential Q32 Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Q32 Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.2 M | |
| Cash And Short Term Investments | 82.7 M |
Q32 Bio Technical Analysis
Q32 Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Q32 Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Q32 Bio. In general, you should focus on analyzing Q32 Stock price patterns and their correlations with different microeconomic environments and drivers.
Q32 Bio Predictive Forecast Models
Q32 Bio's time-series forecasting models is one of many Q32 Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Q32 Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Q32 Bio
Checking the ongoing alerts about Q32 Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Q32 Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Q32 Bio generated a negative expected return over the last 90 days | |
| Q32 Bio has high historical volatility and very poor performance | |
| Q32 Bio has high likelihood to experience some financial distress in the next 2 years | |
| Q32 Bio was previously known as Homology Medicines and was traded on NASDAQ Exchange under the symbol FIXX. | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Q32 Bio generates negative cash flow from operations | |
| About 74.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Q32 Bio Trading Down 0.9 percent - Heres Why - MarketBeat |
Check out Q32 Bio Backtesting, Q32 Bio Valuation, Q32 Bio Correlation, Q32 Bio Hype Analysis, Q32 Bio Volatility, Q32 Bio History as well as Q32 Bio Performance. For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.50) | Revenue Per Share (1.24) |
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Q32 Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.